Literature DB >> 3941141

Chiari innominate osteotomy in adults. Technique, indications and contra-indications.

D A Reynolds.   

Abstract

The results are reported of 44 consecutive Chiari innominate osteotomies performed on 39 adult patients aged between 18 and 55 years for symptoms arising from disproportion between the acetabulum and the femoral head. Predisposing causes included congenital dysplasia of the acetabulum, congenital subluxation of the hip, and Perthes' disease. Follow-up averaged 5 years 2 months. Four pre-operative categories of dysplasia and degeneration were recognised. The analysis of the results from each category made possible the recognition of clinical and radiological features likely to provide a satisfactory result. Of 32 cases now considered to have been selected appropriately, 29 (90%) achieved a significant and apparently lasting improvement. In the other 12 cases there were 9 failures--an unacceptable proportion. The features predisposing to these poor results are discussed. The operation is not difficult. It is safe, and is less demanding than the complex alternative "double", "triple" and "dial" osteotomies. In successful cases there is reduction in symptoms and in limp, and improvement of radiological appearances beginning six months after surgery and progressing to a maximum recovery two to three years later.

Entities:  

Mesh:

Year:  1986        PMID: 3941141

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  10 in total

1.  Hip stress reduction after Chiari osteotomy.

Authors:  S Herman; A Jaklic; S Herman; A Iglic; V Kralj-Iglic
Journal:  Med Biol Eng Comput       Date:  2002-07       Impact factor: 2.602

2.  A computer model for evaluating the osteotomy parameters of Chiari pelvic osteotomy.

Authors:  Mohsen Karami; Dariush Gouran Savadkoohi; Ali Ghadirpoor; Sina Rahimpour; Sina Rahimpoor; Mahmood Azghani; Farzam Farahmand
Journal:  Int Orthop       Date:  2009-04-08       Impact factor: 3.075

3.  Dome osteotomy of the pelvis using a modified trochanteric osteotomy for acetabular dysplasia.

Authors:  Qin Sheng Hu; Rehan Ul-Haq; Kyung Soon Park; Taek Rim Yoon; Keun Bae Lee
Journal:  Int Orthop       Date:  2011-05-02       Impact factor: 3.075

4.  Late results of Chiari's pelvic osteotomy. A follow-up of 171 adult hips.

Authors:  M Zlatić; B Radojević; C Lazović; I Lupulović
Journal:  Int Orthop       Date:  1988       Impact factor: 3.075

5.  High survival of dome pelvic osteotomy in patients with early osteoarthritis from hip dysplasia.

Authors:  Takashi Sakai; Takashi Nishii; Masaki Takao; Kenji Ohzono; Nobuhiko Sugano
Journal:  Clin Orthop Relat Res       Date:  2012-02-22       Impact factor: 4.176

6.  Modified rotational acetabular osteotomy (RAO) for advanced osteoarthritis of the hip joint in the middle-aged person. First report.

Authors:  H Yano; S Sano; Y Nagata; K Tabuchi; S Okinaga; H Seki; T Suyama
Journal:  Arch Orthop Trauma Surg       Date:  1990       Impact factor: 3.067

7.  Triple pelvic osteotomy as treatment for osteoarthritis secondary to developmental dysplasia of the hip.

Authors:  Dirk Janssen; Klaus Kalchschmidt; Bernd-Dietrich Katthagen
Journal:  Int Orthop       Date:  2009-02-12       Impact factor: 3.075

Review 8.  Open treatment of dysplasia-other than PAO: does it have to be a PAO?

Authors:  Kotaro R Shibata; Shuichi Matsuda; Marc R Safran
Journal:  J Hip Preserv Surg       Date:  2015-05-13

9.  Treatment outcome of dome osteotomy of the pelvis combined with trochanteric advancement for sequelae of Perthes' disease.

Authors:  Asep Santoso; Pramod Shaligram Ingale; Ik-Sun Choi; Young-Rok Shin; Kyung-Soon Park; Taek-Rim Yoon
Journal:  Acta Orthop Traumatol Turc       Date:  2018-03-26       Impact factor: 1.511

10.  Good long-term outcomes of the hip Chiari osteotomy in adolescents and adults with hip dysplasia: a systematic review.

Authors:  Koen Willemsen; Menco J S Niemeyer; Netanja I Harlianto; Said Sadiqi; Peter R Seevinck; Ralph J B Sakkers; Harrie Weinans; Bart C H Van der Wal
Journal:  Acta Orthop       Date:  2022-02-04       Impact factor: 3.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.